Wan-Tai M Au-Yeung1, Per G Reinhall2, Jeanne E Poole2, Jill Anderson3, George Johnson3, Ross D Fletcher4, Hans J Moore4, Daniel B Mark5, Kerry L Lee5, Gust H Bardy6. 1. University of Washington, Seattle, Washington. Electronic address: wantai@uw.edu. 2. University of Washington, Seattle, Washington. 3. Seattle Institute for Cardiac Research, Seattle, Washington. 4. Washington DC Veterans Administration Medical Center, Washington, District of Columbia. 5. Duke University, Durham, North Carolina. 6. University of Washington, Seattle, Washington; Seattle Institute for Cardiac Research, Seattle, Washington.
Abstract
BACKGROUND: In the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), a significant fraction of the patients with congestive heart failure ultimately did not die suddenly of arrhythmic causes. Patients with CHF will benefit from better tools to identify if implantable cardioverter-defibrillator (ICD) therapy is needed. OBJECTIVES: We aimed to identify predictor variables from baseline SCD-HeFT patients' R-R intervals that correlate to arrhythmic sudden cardiac death (SCD) and mortality and to design an ICD therapy screening test. METHODS: Ten predictor variables were extracted from prerandomization Holter data from 475 patients enrolled in the ICD arm of theSCD-HeFT by using novel and traditional heart rate variability methods. All variables were correlated to SCD using the Mann-Whitney-Wilcoxon test and receiver operating characteristic analysis. ICD therapy screening tests were designed by minimizing the cost of false classifications. Survival analysis, including log-rank test and Cox models, was also performed. RESULTS: A short-term fractal exponent, α1, and a long-term fractal exponent, α2, from detrended fluctuation analysis, the ratio of low- to high-frequency power, the number of premature ventricular contractions per hour, and the heart rate turbulence slope are all statistically significant for predicting the occurrences of SCD (P < .001) and survival (log-rank, P < .01). The most powerful multivariate predictor tool using the Cox proportional hazards regression model was α2 with a hazard ratio of 0.0465 (95% confidence interval 0.00528-0.409; P < .01). CONCLUSION: Predictor variables extracted from R-R intervals correlate to the occurrences of SCD and distinguish survival functions among patients with ICDs in SCD-HeFT. We believe that SCD prediction models should incorporate Holter-based R-R interval analysis to refine ICD patient selection, especially to exclude patients who are unlikely to benefit from ICD therapy.
RCT Entities:
BACKGROUND: In the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), a significant fraction of the patients with congestive heart failure ultimately did not die suddenly of arrhythmic causes. Patients with CHF will benefit from better tools to identify if implantable cardioverter-defibrillator (ICD) therapy is needed. OBJECTIVES: We aimed to identify predictor variables from baseline SCD-HeFT patients' R-R intervals that correlate to arrhythmic sudden cardiac death (SCD) and mortality and to design an ICD therapy screening test. METHODS: Ten predictor variables were extracted from prerandomization Holter data from 475 patients enrolled in the ICD arm of the SCD-HeFT by using novel and traditional heart rate variability methods. All variables were correlated to SCD using the Mann-Whitney-Wilcoxon test and receiver operating characteristic analysis. ICD therapy screening tests were designed by minimizing the cost of false classifications. Survival analysis, including log-rank test and Cox models, was also performed. RESULTS: A short-term fractal exponent, α1, and a long-term fractal exponent, α2, from detrended fluctuation analysis, the ratio of low- to high-frequency power, the number of premature ventricular contractions per hour, and the heart rate turbulence slope are all statistically significant for predicting the occurrences of SCD (P < .001) and survival (log-rank, P < .01). The most powerful multivariate predictor tool using the Cox proportional hazards regression model was α2 with a hazard ratio of 0.0465 (95% confidence interval 0.00528-0.409; P < .01). CONCLUSION: Predictor variables extracted from R-R intervals correlate to the occurrences of SCD and distinguish survival functions among patients with ICDs in SCD-HeFT. We believe that SCD prediction models should incorporate Holter-based R-R interval analysis to refine ICDpatient selection, especially to exclude patients who are unlikely to benefit from ICD therapy.
Authors: Jari M Tapanainen; Poul Erik Bloch Thomsen; Lars Køber; Christian Torp-Pedersen; Timo H Mäkikallio; Aino-Maija Still; Kai S Lindgren; Heikki V Huikuri Journal: Am J Cardiol Date: 2002-08-15 Impact factor: 2.778
Authors: Darrel P Francis; Keith Willson; Panagiota Georgiadou; Roland Wensel; L Ceri Davies; Andrew Coats; Massimo Piepoli Journal: J Physiol Date: 2002-07-15 Impact factor: 5.182
Authors: Kenneth C Bilchick; Barry Fetics; Ronnie Djoukeng; Susan Gross Fisher; Ross D Fletcher; Steven N Singh; Erez Nevo; Ronald D Berger Journal: Am J Cardiol Date: 2002-07-01 Impact factor: 2.778
Authors: Bert Vandenberk; M Juhani Junttila; Tomas Robyns; Christophe Garweg; Joris Ector; Heikki V Huikuri; Rik Willems Journal: Ann Noninvasive Electrocardiol Date: 2018-09-28 Impact factor: 1.468
Authors: Gabriella Captur; Audrey L Karperien; Alun D Hughes; Darrel P Francis; James C Moon Journal: Nat Rev Cardiol Date: 2016-10-06 Impact factor: 32.419